The association of changes in depression severity after the onset of the COVID-19 pandemic and viral nonsuppression among people with HIV
Tarfa Verinumbe(Albert Einstein College of Medicine), Oluwaseun Falade‐Nwulia(Johns Hopkins University), Anthony T. Fojo(Johns Hopkins University), Jarratt D. Pytell(Kaiser Permanente), Geetanjali Chander(Johns Hopkins University), LaQuita N. Snow(National Institutes of Health), Jeanne Keruly(Johns Hopkins University), Heidi E. Hutton(Johns Hopkins University), Richard D. Moore(Johns Hopkins University), Catherine R. Lesko(Johns Hopkins University)
Cited by 0
Related Papers
Effect of Early versus Deferred Antiretroviral Therapy for HIV on Survival
|New England Journal of Medicine|2009|1.1k
Hepatitis C Guidance 2018 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection
|Clinical Infectious Diseases|2018|728
Oral Direct-Acting Agent Therapy for Hepatitis C Virus Infection
|Annals of Internal Medicine|2017|694
Hepatotoxicity associated with nevirapine or efavirenz-containing antiretroviral therapy: Role of hepatitis C and B infections
|Hepatology|2002|521
Rising Obesity Prevalence and Weight Gain Among Adults Starting Antiretroviral Therapy in the United States and Canada
|AIDS Research and Human Retroviruses|2015|335